Pain management for adolescents discussed in June 7 ADA webinar

Safe and effective treatment of acute postoperative pain is essential for patient satisfaction and successful practice in dentistry. Because of the growing crisis from illicit and prescription opioid abuse, dentists and other practitioners treating acute pain must understand the risks and benefits of prescribing opioid analgesics such as hydrocodone and oxycodone for managing acute postoperative pain. 

A free webinar Thursday, June 7, at 8 a.m. PST will address concerns about managing pain when treating adolescents in the dental practice.

Hosted by the ADA and presented by Paul A. Moore, DMD, PhD, who received his dental and pharmacology degrees from the University of Pittsburgh School of Dental Medicine, the one-hour webinar will allow participants to:

  • Explain the rationale for combining the two peripherally acting analgesics — acetaminophen and ibuprofen.
  • List factors that may contribute to young adult patients being at greater risk of opioid abuse following dental surgery.
  • Provide instructional elements recommended when counseling patients about safe and responsible prescribing of opioids following a dental procedure.

The webinar offers one hour of C.E. credit.

Register online for the webinar in under two minutes.

Related Items

On the legislative front, in California alone, more than two dozen bills that address opioid prescription and misuse are working their way through the Legislature, including several by Assemblymember Jim Wood, DDS. Meanwhile, CDA continues to provide education and resources on opioid prescribing to members and dentists throughout California. In May at CDA Presents The Art and Science of Dentistry in Anaheim, CDA Public Affairs will host “Clinical and Legal Considerations for Prescribing Controlled Substances.”

The ADA on March 26 adopted a new policy to combat the opioid epidemic, calling it the potential first of its kind by a major health professional organization to support mandates on opioid prescription limits and continuing education. “I call upon dentists everywhere to double down on their efforts to prevent opioids from harming our patients and their families,” said ADA President Joseph P. Crowley, DDS, in a press release. The Interim Board Policy on Opioid Prescribing addresses continuing education, dosage and duration, and prescription and drug monitoring.